Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate vs Propofol in Gastric Endoscopic Submucosal Dissection
NCT05407870Completed
- Sponsor
- Korea University Anam Hospital
- Start
- Jun 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of etomidate (2 arms), sponsored by Korea University Anam Hospital. Primary endpoint: Respiratory adverse event. Started Jun 2022; status: completed.
02
Drugs
etomidate
Beyond the preview
Go deeper on NCT05407870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05407870.